ASND
Ascendis Pharma A/S
$220.42
+$10.26(+4.88%)
75
Overall
--
Value
90
Tech
60
Quality
Market Cap
$11.93B
Volume
1.43M
52W Range
$118.03 - $229.94
Target Price
$258.13
EPS Estimates Overview
| Current Quarter | $0.2 | Next Quarter | $0.56 |
| Current Year | $-3.41 | Next Year | $3.21 |
| QoQ Growth | +180.0% | YoY Growth | +194.1% |
| 3Y EPS CAGR | +0.0% | Target Price | $258.13 |
| Consensus | Buy | Upside | +17.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ASND | $220.42 | +4.9% | 1.43M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |